Evaluation of the anti-tumour efficacy of Abemaciclib, a dual CDK4/6 inhibitor, both as a single agent and combined with radiotherapy in Medulloblastoma (2018)
Experts
Dr
Laura Genovesi
Senior Program Manager, Strategic Projects
Health Translation Queensland
Faculty of Health, Medicine and Behavioural Sciences
